Drawing for ORIEN

USPTO serial 86271578

ORIEN

Reviewed by CopyMark Law Group

Reg. 6064396Status 702Renewal
Filing date
Status date
Registration date
May 26, 2020
Examiner
NEVILLE, BRIAN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ORIEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen K. Won

Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.One Financial CenterBoston, MA 02111United States

Goods and services

ClassDescriptionStatusFirst use
035Personnel selection services in the fields of medical and scientific research, namely, selection of patients for clinical cancer therapy studies for others; clinical trial matching services, namely, matching patients who have cancer with organizations conducting or administering clinical trials for medical researchACTIVE—
041medical educational and training services, namely, conducting lectures, seminars, workshops, conferences, internship training programs, fellowship training programs, and medical residency training programs, all in the field of cancerACTIVE—
042medical, clinical, and scientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; data collection for research purposes, namely, data mining and pattern recognition; designing clinical research studies for others; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments; scientific and technological services, namely, research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting clinical studies in the field of cancer therapy for others; technological and scientific data analysis in the field of oncology; scientific and research consulting services, namely, technical data collection, research analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; technological and scientific data analysis in the field of oncologyACTIVE—
044medical evaluation services to collect data about patients related to research, namely, conducting medical evaluations of a patient's general health and fitness to determine whether they can safely participate in clinical trials; healthcare counseling services, namely, providing medical information relating to cancer screening, cancer diagnosis, cancer prognosis, cancer treatment, cancer relapse, palliative care relating to cancer, integrative medicine relating to cancer, and cancer survivorship; healthcare services, namely, providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 9, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 9, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 11, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 11, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 29, 2025E815TEAS SECTION 8 & 15 RECEIVED—
May 26, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 26, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 23, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 22, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 9, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 9, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 23, 2020IUAFUSE AMENDMENT FILED—
Mar 23, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 17, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 5, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 5, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 5, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 7, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2019DOCKASSIGNED TO EXAMINER—
Mar 28, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2019ALIEASSIGNED TO LIE—
Feb 26, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 28, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 29, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 28, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 25, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 23, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 23, 2016RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 23, 2016RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 23, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 23, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Sep 23, 2015CNSLSUSPENSION LETTER WRITTEN—
Sep 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 20, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 20, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 20, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2014DOCKASSIGNED TO EXAMINER—
Jun 5, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 5, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 16, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance